Back to Charles Schwab Investment Management Inc. Charles Schwab Investment Management Inc.

ARWR

31 quarters

Position history for Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc.'s holdings in Arrowhead Pharmaceuticals, Inc.

Yes. Charles Schwab Investment Management holds 923,927 shares of ARWR (Arrowhead Pharmaceuticals), worth $75.3M, as of its Q2 2026 13F filing. It reduced the position by 268,158 shares (-22.5%) from Q1 2026. Charles Schwab Investment Management has held ARWR in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$75.3M

Current Shares

923,927

Total Value Change

+$69.3M

Total Shares Change

+442,184

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
923,927
-22.5%
$75.3M0.0%$81.51
0
2026-Q1
Decreased
1.2M
-11.9%
$74.7M0.0%$62.70
0
2025-Q4
Increased
1.4M
+0.6%
$89.9M0.0%$66.39
30
2025-Q3
Increased
1.3M
+15.0%
$46.4M0.0%$34.49
33
2025-Q2
Increased
1.2M
+13.1%
$18.5M0.0%$15.80
32
2025-Q1
Increased
1M
+1.7%
$13.2M0.0%$12.74
28
2024-Q4
Increased
1M
+1.1%
$19.1M0.0%$18.80
29
2024-Q3
Increased
1M
+1.3%
$19.5M0.0%$19.37
29
2024-Q2
Increased
994,361
+1.1%
$25.8M0.0%$25.99
29
2024-Q1
Increased
983,755
+16.3%
$28.1M0.0%$28.60
33
2023-Q4
Increased
845,979
+0.1%
$25.9M0.0%$30.60
29
2023-Q3
Decreased
844,985
-26.2%
$22.7M0.0%$26.87
0
2023-Q2
Decreased
1.1M
-1.1%
$40.8M0.0%$35.66
0
2023-Q1
Increased
1.2M
+1.7%
$29.4M0.0%$25.40
29
2022-Q4
Increased
1.1M
+3.1%
$46.2M0.0%$40.56
30
2022-Q3
Increased
1.1M
+2.3%
$36.5M0.0%$33.05
30
2022-Q2
Decreased
1.1M
-0.6%
$38M0.0%$35.21
0
2022-Q1
Increased
1.1M
+3.4%
$49.9M0.0%$45.99
30
2021-Q4
Increased
1M
+1.9%
$69.6M0.0%$66.30
30
2021-Q3
Increased
1M
+2.4%
$64.4M0.0%$62.43
30
2021-Q2
Increased
1M
+4.8%
$83.4M0.0%$82.82
31
2021-Q1
Increased
960,347
+3.5%
$63.7M0.0%$66.31
31
2020-Q4
Increased
927,495
+1.4%
$71.2M0.0%$76.73
30
2020-Q3
Increased
914,717
+25.4%
$39.4M0.0%$43.06
36
2020-Q2
Increased
729,508
+3.8%
$31.5M0.0%$43.19
30
2020-Q1
Increased
703,026
+11.8%
$20.2M0.0%$28.77
32
2019-Q4
Increased
629,061
+4.1%
$39.9M0.0%$63.43
30
2019-Q3
Increased
604,362
+1.5%
$17M0.0%$28.18
29
2019-Q2
Decreased
595,553
-4.4%
$15.8M0.0%$26.50
0
2019-Q1
Increased
622,924
+29.3%
$11.4M0.0%$18.35
35
2018-Q4
First report
481,743
-
$6M0.0%$12.42
0

Other major holders of ARWR: BlackRock, Inc., Vanguard Group Inc., Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used